Keating Laurie
- SEC CIK
- 0001620743
No open-market purchases or sales filed in the past year.
Current role at each company
- KLRS Kalaris Therapeutics, Inc.Directoras of Aug 3, 2026
- PEPG PepGen Inc.Directoras of Jun 22, 2026
- IMRX Immuneering CorpDirectoras of Jun 11, 2026
- IMGO Imago BioSciences, Inc.Directoras of Jan 11, 2023
- ALNY Alnylam Pharmaceuticals, Inc.EVP, Chief Legal Officeras of Aug 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Keating Laurie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PEPG PepGen Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2023 (view filing) | May 6, 2022 | 258 daysLate | Keating LaurieDirector | PPurchase | +4.17K | $12.00 | +$50.0K | New position4.17K after |
IMRX Immuneering Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 (view filing) | May 16 | 1 day | Keating LaurieDirector | PPurchaseClass A Common Stock | +7.00K | $5.00 | +$35.0K | +100.0%14.0K after | |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Keating LaurieDirector | PPurchaseClass A Common Stock | +7.00K | $15.00 | +$105.0K | New position7.00K after |
ALNY Alnylam Pharmaceuticals, Inc.
EVP, Chief Legal Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Keating LaurieEVP, Chief Legal Officer | SSale | −10.0K | $188.95 | −$1.89M | −66.1%5.13K after | |
| Jul 14, 2021 (view filing) | Jul 12 | 2 days | Keating LaurieEVP, Chief Legal Officer | SSale | −6.81K | $178.96 | −$1.22M | −57.0%5.13K after | 2 lots |